Evaluation of 12 Blood Glucose Monitoring Systems for Self-Testing: System Accuracy and Measurement Reproducibility
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Systems for self-monitoring of blood glucose (SMBG) have to provide accurate and reproducible blood glucose (BG) values in order to ensure adequate therapeutic decisions by people with diabetes. MATERIALS AND METHODS: Twelve SMBG systems were compared in a standardized manner under controlled laboratory conditions: nine systems were available on the German market and were purchased from a local pharmacy, and three systems were obtained from the manufacturer (two systems were available on the U.S. market, and one system was not yet introduced to the German market). System accuracy was evaluated following DIN EN ISO (International Organization for Standardization) 15197:2003. In addition, measurement reproducibility was assessed following a modified TNO (Netherlands Organization for Applied Scientific Research) procedure. Comparison measurements were performed with either the glucose oxidase method (YSI 2300 STAT Plus™ glucose analyzer; YSI Life Sciences, Yellow Springs, OH) or the hexokinase method (cobas(®) c111; Roche Diagnostics GmbH, Mannheim, Germany) according to the manufacturer's measurement procedure. RESULTS: The 12 evaluated systems showed between 71.5% and 100% of the measurement results within the required system accuracy limits. Ten systems fulfilled with the evaluated test strip lot minimum accuracy requirements specified by DIN EN ISO 15197:2003. In addition, accuracy limits of the recently published revision ISO 15197:2013 were applied and showed between 54.5% and 100% of the systems' measurement results within the required accuracy limits. Regarding measurement reproducibility, each of the 12 tested systems met the applied performance criteria. CONCLUSIONS: In summary, 83% of the systems fulfilled with the evaluated test strip lot minimum system accuracy requirements of DIN EN ISO 15197:2003. Each of the tested systems showed acceptable measurement reproducibility. In order to ensure sufficient measurement quality of each distributed test strip lot, regular evaluations are required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkes, J. L., Slatin, S. L., Pardo, S., & Ginsberg, B. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1143 · Cited by 620
System Accuracy Evaluation of 27 Blood Glucose Monitoring Systems According to DIN EN ISO 15197
Freckmann, G., Baumstark, A., Jendrike, N., Zschornack, E., Kocher, S., Tshiananga, J., Heister, F., & Haug, C. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0128 · Cited by 195 · cited 1×
“5% of the measurement results within the required accuracy limits; comparable results for some of the investigated systems have been reported in other studies.(6,8,17) Considering the recently published revision ISO 15197:2013,(5) the systems’ measurement results within the required limits varied between 54.”
Self-citationBrazg, R. L., Klaff, L. J., & Parkin, C. G. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700117 · Cited by 68 · cited 1×
“5% of the measurement results within the required accuracy limits; comparable results for some of the investigated systems have been reported in other studies.(6,8,17) Considering the recently published revision ISO 15197:2013,(5) the systems’ measurement results within the required limits varied between 54.”
(1994) · doi:10.2337/diacare.17.6.595 · Cited by 32
Cited by
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685
Comparative accuracy of 17 point-of-care glucose meters
Ekhlaspour, L., Mondesir, D., Lautsch, N., Balliro, C., Hillard, M., Magyar, K., Radocchia, L. G., Esmaeili, A., Sinha, M., & Russell, S. J. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816672237 · Cited by 127
Freckmann, G., Schmid, C., Baumstark, A., Rutschmann, M., Haug, C., & Heinemann, L. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815580160 · Cited by 70
Self-citationPerformance of Cleared Blood Glucose Monitors
Klonoff, D. C., & Prahalad, P. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815584797 · Cited by 59
Freckmann, G., Link, M., Schmid, C., Pleus, S., Baumstark, A., & Haug, C. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0085 · Cited by 46
Self-citationHerrero, P., Pesl, P., Bondia, J., Reddy, M., Oliver, N., Georgiou, P., & Toumazou, C. (2015) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2015.02.003 · Cited by 43
A review of blood glucose monitor accuracy
King, F., Ahn, D., Hsiao, V., Porco, T., & Klonoff, D. C. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0232 · Cited by 37
(2015) · doi:10.1177/1932296815580161 · Cited by 31
Self-citationVahlsing, T., Delbeck, S., Leonhardt, S., & Heise, H. M. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818798347 · Cited by 28
“Self-management plans for glycemic control usually require a measurement of (finger) capillary blood, as performed by widely used blood glucose test systems;(1) see report on exemplary devices that were tested for their analytical performance.(2) Alternate testing sites have also been suggested, but interferences from…”
MethodYu-Fei, W., Wei-Ping, J., Ming-Hsun, W., Miao-O, C., Ming-Chang, H., Chi-Pin, W., & Ming-Shih, L. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817705143 · Cited by 15
Metadata
- Authors
- Freckmann, G., Baumstark, A., Schmid, C., Pleus, S., Link, M., & Haug, C.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2014-02
- Volume
- 16
- Issue
- 2
- Pages
- 113-122
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W1530731019
- Cited by
- 77
- References
- 4
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.